.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Covington
Merck
Cantor Fitzgerald
Cipla
Chubb
Medtronic
Teva
Farmers Insurance
Deloitte

Generated: June 24, 2017

DrugPatentWatch Database Preview

SULAR Drug Profile

« Back to Dashboard

What is the patent landscape for Sular, and what generic Sular alternatives are available?

Sular is a drug marketed by Covis Pharma Bv and is included in one NDA.

The generic ingredient in SULAR is nisoldipine. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the nisoldipine profile page.

Summary for Tradename: SULAR

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list5
Bulk Api Vendors: see list60
Clinical Trials: see list3
Patent Applications: see list3,703
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SULAR at DailyMed

Pharmacology for Tradename: SULAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-008Jan 2, 2008ABRXYesYes► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-005Jan 2, 2008ABRXYesYes► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-002Feb 2, 1995DISCNYesNo► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-004Feb 2, 1995DISCNYesNo► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-001Feb 2, 1995DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SULAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-001Feb 2, 19954,892,741► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-004Feb 2, 19954,703,038► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-007Jan 2, 20085,626,874► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-002Feb 2, 19954,703,038► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-008Jan 2, 20085,422,123► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: SULAR

Drugname Dosage Strength RLD Submissiondate
nisoldipineExtended-release Tablets8.5 mg and 17 mgSular3/2/2009
nisoldipineExtended-release Tablets25.5 mg and 34 mgSular11/28/2008
nisoldipineExtended-release Tablets20 mg and 30 mgSular11/7/2007
nisoldipineExtended-release Tablets40 mgSular6/11/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Medtronic
US Department of Justice
Colorcon
Cipla
Cerilliant
Dow
Johnson and Johnson
Moodys
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot